Valuation: T&R Biofab Co., Ltd.

Market Cap 80.64B 60.4M 54.83M 50.65M 45.7M 86.27M 5.64B 89.57M 610M 241M 3.05B 227M 222M 9.62B P/E 2024
-12.2x
P/E 2025 -3.91x
Enterprise Value 102B 76.66M 69.59M 64.28M 57.99M 109M 7.16B 114M 775M 306M 3.86B 288M 282M 12.21B EV / Sales 2024
25.1x
EV / Sales 2025 7.45x
Free-Float
85.08%
Yield 2024 *
-
Yield 2025 -
01-21 T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5% MT
22/09/24 T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index CI
04/08/24 T&R Biofab Co., Ltd. announced that it has received KRW 7 billion in funding from BTC Investment CI
22/07/24 T&R Biofab Co., Ltd. announced that it expects to receive KRW 7 billion in funding from BTC Investment and another investor CI
03/07/24 T&R Biofab Co., Ltd. announced that it has received KRW 2.99999656 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation CI
24/06/24 T&R Biofab Co., Ltd. announced that it expects to receive KRW 2.9999956 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation CI
21/12/23 T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc. CI
13/12/23 T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc. CI
18/10/23 CJ Foods Partners with T&R Biofab to Shape the Future of Food CI
03/08/23 T&R Biofab Co., Ltd. announced that it has received KRW 24 billion in funding CI
25/07/23 T&R Biofab Co., Ltd. announced that it expects to receive KRW 24 billion in funding CI
15/05/23 T&R Biofab Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
20/09/21 T&R Biofab Co., Ltd.(KOSDAQ:A246710) added to S&P Global BMI Index CI
1 day-1.63%
1 week-5.42%
Current month-7.03%
1 month-16.65%
3 months-34.29%
6 months-32.05%
Current year-56.73%
1 week 1,650
Extreme 1650.00000000
1,889
1 month 1,650
Extreme 1650.00000000
2,115
Current year 1,650
Extreme 1650.00000000
4,800
1 year 1,330
Extreme 1330
4,925
3 years 1,127
Extreme 1127
9,250
5 years 1,127
Extreme 1127
28,250
10 years 1,127
Extreme 1127
37,916.67
Manager TitleAgeSince
Chief Executive Officer 56 -
Director of Finance/CFO 53 -
Chief Operating Officer 57 -
Director TitleAgeSince
Director/Board Member 56 -
Director/Board Member 41 -
Director/Board Member 51 -
Date Insider Type Main position Quantity % Market Cap. Importance
06/03/25 Others 3,392 0.0157%
06/03/25 Others 15,492 0.0719%
26/02/25 Buy

Chief Executive Officer

2,100 0.0097%
Change 5-day change 1-year change 3-year change Capi.($)
-1.63%-5.42%+35.36%-77.36% 61.4M
-0.27%-4.65%-19.84%+2.97% 181B
-1.63%-1.26%-0.47%+33.49% 125B
-0.05%-0.89%-12.12%+9.21% 121B
+1.12%-0.96%-41.94%+2.39% 90.52B
-1.33%-0.94%-4.16%+76.88% 66.9B
-0.17%+0.10%+11.65%-8.10% 58.68B
+0.71%-1.64%+3.11%+46.12% 54.38B
+0.86%-0.15%-1.84%+38.65% 48.46B
+0.89%+4.81%+4.00%-1.05% 35.4B
Average -0.16%-1.35%-2.62%+12.32% 78B
Weighted average by Cap. -0.20%-1.52%-10.60%+19.27%

Financials

2024 2025
Net sales 4.87B 3.65M 3.31M 3.06M 2.76M 5.21M 341M 5.41M 36.89M 14.59M 184M 13.7M 13.41M 581M 26.97B 20.2M 18.34M 16.94M 15.28M 28.85M 1.89B 29.95M 204M 80.73M 1.02B 75.78M 74.19M 3.22B
Net income -7.68B -5.75M -5.22M -4.82M -4.35M -8.21M -537M -8.53M -58.12M -22.99M -290M -21.58M -21.12M -916M -31.95B -23.93M -21.73M -20.07M -18.11M -34.18M -2.24B -35.49M -242M -95.65M -1.21B -89.79M -87.9M -3.81B
Net Debt 28.78B 21.56M 19.57M 18.08M 16.31M 30.79M 2.01B 31.97M 218M 86.16M 1.09B 80.88M 79.18M 3.43B 21.7B 16.25M 14.76M 13.63M 12.3M 23.22M 1.52B 24.1M 164M 64.97M 820M 60.99M 59.7M 2.59B
Projected Income Statement - Annual - T&R Biofab Co., Ltd.
Logo T&R Biofab Co., Ltd.
T&R Biofab Co Ltd is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The Company distributes its products within the domestic market and to overseas markets.
Employees
86
Date Price Change Volume
17/11/26 ₩1,692.00 -1.63% 303,298
17/11/26 ₩1,720.00 -1.15% 226,715
16/11/26 ₩1,740.00 -3.81% 310,901
13/11/26 ₩1,809.00 -2.00% 189,713
12/11/26 ₩1,846.00 +1.65% 375,733
  1. Stock Market
  2. Stocks
  3. A246710 Stock